A groundbreaking, home-grown cancer therapy trial just hit another milestone and there are hopes to bring it to Kiwis, writes Jamie Morton.
Michele Leggott
A groundbreaking, home-grown cancer therapy trial just hit another milestone and there are hopes to bring it to Kiwis, writes Jamie Morton. Michele Leggott.
The goal of CAR T-cell cancer therapy becoming a standard of care in New Zealand is another step closer with patient enrolment completed and a total of 30 patients treated within the Malaghan Institute’s ENABLE phase 1 safety trial, says Malaghan .